课题基金 / 基金详情

Myeloid-lineage cells and immunopathology in Leishmania braziliensis

Myeloid-lineage cells and immunopathology in Leishmania braziliensis
巴西利什曼原虫的骨髓谱系细胞和免疫病理学
批准号:
7900707
负责人:
PHILLIP SCOTT
金额:
$63.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-01 至 2015-11-30

项目摘要

项目成果

PHILLIP SCOTT的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):利什曼病是巴西的一个主要公共卫生问题,我们提出的实验将促进我们对这种疾病的了解,目标是更有效地控制疾病。该项目涉及美国宾夕法尼亚大学和马里兰大学以及巴西巴伊亚大学之间的合作。巴西乳杆菌感染与强烈的炎症反应有关,这是引起疾病的主要因素。巴西乳杆菌患者表现出循环促炎单核细胞的显著增加,表明这些细胞有助于这些患者观察到的严重病理性炎症反应。为了获得关于髓系细胞在该病中的作用的基本信息,我们将在巴西皮肤利什曼病患者的表型和功能水平上评估循环和组织定位的髓系细胞。我们还将确定促炎单核细胞的相对频率和/或其分泌产物的水平是否可作为治疗成功的预测性生物标志物。如果我们的研究表明促炎单核细胞在疾病进展中起致病作用,这将为开发针对巴西乳杆菌患者的促炎效应物的新免疫疗法提供令人信服的理论依据。我们假设,促炎单核细胞的扩张,以及它们随后在病变内分化为树突状细胞,导致炎症细胞因子和趋化因子的过量产生,从而募集额外的T细胞和单核细胞到病变处。为了解决这一假设,我们将对利什曼病患者病变(Aim 2)中的循环单核细胞(Aim 1)和髓系人群进行表型和功能表征。在Aim 3中,我们将直接测试促炎单核细胞或其分泌产物是否在早期皮肤利什曼病的疾病进展和治疗反应中作为有用的生物标志物。这些研究将增强我们对人类单核细胞生物学的基本理解,并使我们能够应用这些信息来更好地制定控制皮肤利什曼病的策略。
英文摘要
DESCRIPTION (provided by applicant): Leishmaniasis is a major public health problem in Brazil, and we propose experiments that will advance our understanding of this disease with the goal of more effective disease control. This project involves collaborations between the Universities of Pennsylvania and Maryland in the USA, and the University of Bahia in Brazil. L. braziliensis infection is associated with a strong inflammatory response that is the major factor in causing disease. Patients with L. braziliensis exhibit a pronounced increase in circulating proinflammatory monocytes, suggesting that these cells contribute to the severe pathologic inflammatory response observed in these patients. To obtain fundamental information about the role of myeloid-lineage cells in this disease, we will evaluate circulating and tissue-localized myeloid cells at a phenotypic and functional level in cutaneous leishmaniasis patients in Brazil. We will also determine if the relative frequency of proinflammatory monocytes and/or levels of their secreted products serve as predictive biomarkers of treatment success. If our studies indicate that proinflammatory monocytes play a causative role in the disease progression, it would provide a convincing rationale for the development of new immunotherapies specifically targeting proinflammatory effectors for L. braziliensis patients. We hypothesize that the expansion of proinflammatory monocytes, and their subsequent differentiation into dendritic cells within lesions, results in the excess production of inflammatory cytokines and chemokines that recruit additional T cells and monocytes to the lesion. To address this hypothesis, we will phenotypically and functionally characterize both circulating monocytes (Aim 1) and the myeloid-lineage populations in the lesion (Aim 2) of leishmaniasis patients. In Aim 3 we will directly test if either proinflammatory monocytes or their secreted products serve as useful biomarkers in disease progression and response to therapy in early cutaneous leishmaniasis. These studies will enhance our basic understanding of the biology of human monocytes, and allow us to apply that information to better develop strategies to control cutaneous leishmaniasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2023 Woods Hole Immunoparasitology Meeting
  • 批准号:
    10680864
  • 项目类别:
  • 资助金额:
    $0.7万
  • 财政年份:
    2023
  • 负责人:
    PHILLIP SCOTT
  • 依托单位:
2022 WOODS HOLE IMMUNOPARASITOLOGY MEETING
  • 批准号:
    10458244
  • 项目类别:
  • 资助金额:
    $0.6万
  • 财政年份:
    2022
  • 负责人:
    PHILLIP SCOTT
  • 依托单位:
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis
  • 批准号:
    10329958
  • 项目类别:
  • 资助金额:
    $55.78万
  • 财政年份:
    2020
  • 负责人:
    PHILLIP SCOTT
  • 依托单位:
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis
  • 批准号:
    10556387
  • 项目类别:
  • 资助金额:
    $55.78万
  • 财政年份:
    2020
  • 负责人:
    PHILLIP SCOTT
  • 依托单位:
海外基金